These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2147118

  • 1. Behavioral sensitization following a single apomorphine pretreatment--selective effects on the dopamine release process.
    Wilcox RE, Severson JA, Woodward JJ, Randall PK, Vaughn DM, Riffee WH.
    Brain Res; 1990 Sep 24; 528(1):109-13. PubMed ID: 2147118
    [Abstract] [Full Text] [Related]

  • 2. Behavioral sensitization following subchronic apomorphine treatment--possible neurochemical basis.
    Vaughn DM, Severson JA, Woodward JJ, Randall PK, Riffee WH, Leslie SW, Wilcox RE.
    Brain Res; 1990 Aug 27; 526(1):37-44. PubMed ID: 2150341
    [Abstract] [Full Text] [Related]

  • 3. Single apomorphine pretreatment results in a rapid decline in high-affinity dopamine binding to the striatal dopamine D-2 receptor.
    Severson JA, Randall PK, Wilcox RE.
    Eur J Pharmacol; 1990 Apr 25; 188(4-5):283-6. PubMed ID: 2114303
    [Abstract] [Full Text] [Related]

  • 4. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M, Wiśniewski K.
    Pol J Pharmacol Pharm; 1982 Apr 25; 34(1-3):79-84. PubMed ID: 7167424
    [Abstract] [Full Text] [Related]

  • 5. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF, Salama AI.
    Eur J Pharmacol; 1986 Feb 18; 121(2):181-8. PubMed ID: 3699091
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
    Kovács GL, Szabó G, Penke B, Telegdy G.
    Eur J Pharmacol; 1981 Jan 29; 69(3):313-9. PubMed ID: 6260512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
    King GR, Ellinwood EH, Silvia C, Joyner CM, Xue Z, Caron MG, Lee TH.
    J Pharmacol Exp Ther; 1994 May 29; 269(2):743-9. PubMed ID: 8182540
    [Abstract] [Full Text] [Related]

  • 11. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
    Spampinato U, Girault JA, Danguir J, Savaki HE, Glowinski J, Besson MJ.
    Brain Res Bull; 1986 Feb 29; 16(2):161-6. PubMed ID: 3697784
    [Abstract] [Full Text] [Related]

  • 12. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS, Talmaciu RK, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Aug 29; 238(2):437-46. PubMed ID: 2942676
    [Abstract] [Full Text] [Related]

  • 13. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 29; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701
    [Abstract] [Full Text] [Related]

  • 15. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM, DeLeon-Jones F, Fields JZ, Ritzmann RF.
    Alcohol Drug Res; 1987 Nov 05; 7(1):1-10. PubMed ID: 2431697
    [Abstract] [Full Text] [Related]

  • 16. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
    Ichikawa J, Meltzer HY.
    Brain Res; 1995 Nov 06; 698(1-2):204-8. PubMed ID: 8581482
    [Abstract] [Full Text] [Related]

  • 17. Effects of Estrogen on Striatal Dopamine receptor function in male and female rats.
    Hruska RE, Ludmer LM, Pitman KT, De Ryck M, Silbergeld EK.
    Pharmacol Biochem Behav; 1982 Feb 06; 16(2):285-91. PubMed ID: 7200238
    [Abstract] [Full Text] [Related]

  • 18. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR, Laruelle M, Mouradian MM.
    J Neural Transm (Vienna); 1997 Feb 06; 104(4-5):341-62. PubMed ID: 9295170
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT, Snodgrass SR.
    Brain Res; 1978 Sep 08; 152(3):555-66. PubMed ID: 308384
    [Abstract] [Full Text] [Related]

  • 20. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 08; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.